| Literature DB >> 3143561 |
E B Menachem1, L I Persson, P J Schechter, K D Haegele, N Huebert, J Hardenberg, L Dahlgren, J P Mumford.
Abstract
Vigabatrin, as a single oral dose of 50 mg/kg, was administered to 11 patients with drug-refractory complex partial epilepsy. Serial lumbar punctures were performed prior to and 5 times within the first week following treatment. Cerebrospinal fluid (CSF) concentrations of total GABA, free GABA, homocarnosine, homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and vigabatrin were determined as well as blood vigabatrin levels. CSF GABA, homocarnosine, HVA and 5-HIAA concentrations increased by 6 h after the single dose and remained elevated for up to 5-7 days. In contrast, CSF and blood vigabatrin levels were maximal within the first 24 h and were no longer detectable thereafter. Hence, these results are consistent with vigabatrin acting as an irreversible inhibitor of GABA-transaminase and suggest that it may also increase biogenic amine turnover.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3143561 DOI: 10.1016/0920-1211(88)90025-3
Source DB: PubMed Journal: Epilepsy Res ISSN: 0920-1211 Impact factor: 3.045